CTC
HALO icon

Cetera Trust Company’s Halozyme HALO Stock Holding History

Cetera Trust Company’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$489K Buy
6,250
+50
+0.8% +$3.41K 0.25% 77
2026
Q1 		$401K Hold
6,200
– – 0.23% 85
2025
Q4 		$417K Hold
6,200
– – 0.22% 82
2025
Q3 		$455K Hold
6,200
– – 0.25% 72
2025
Q2 		$323K Buy
6,200
+425
+7% +$24.2K 0.19% 94
2025
Q1 		$369K Buy
5,775
+150
+3% +$8.71K 0.23% 73
2024
Q4 		$269K Buy
5,625
+85
+2% +$4.36K 0.17% 110
2024
Q3 		$317K Hold
5,540
– – 0.19% 99
2024
Q2 		$290K Hold
5,540
– – 0.18% 98
2024
Q1 		$225K Sell
5,540
-100
-2% -$3.75K 0.14% 146
2023
Q4 		$208K Buy
+5,640
New +$212K 0.13% 145

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Cetera Trust Company's HALO Position: Q2 2026 in Review

Cetera Trust Company increased its Halozyme (HALO) stake by 0.81% in Q2 2026, buying an estimated $3.41K and bringing the position to 6,250 shares worth $489K. The position accounts for 0.25% of the portfolio, ranked #77.

Cetera Trust Company first reported a position in HALO in Q4 2023 and has held it in 11 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Cetera Trust Company held 6,250 shares of Halozyme worth $489K as of Q2 2026.
  • Cetera Trust Company bought 50 Halozyme shares in Q2 2026, an estimated $3.41K.
  • Halozyme made up 0.25% of Cetera Trust Company's portfolio in Q2 2026, its #77 holding.
  • Cetera Trust Company first reported a position in Halozyme in Q4 2023 and has held it in 11 quarters since.
  • 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.